Observational studyFrontiers in immunology2025

Camrelizumab-based therapies for the treatment of advanced lung cancer: a prospective, open-label, multicenter, observational, real-world study.

Dong Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.